Cargando…

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses

Immunogenic cell death (ICD) is a powerful trigger eliciting strong immune responses against tumors. However, traditional chemoimmunotherapy (CIT) does not last long enough to induce sufficient ICD, and also does not guarantee the safety of chemotherapeutics. To overcome the disadvantages of the con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jeongrae, Choi, Yongwhan, Yang, Suah, Lee, Jaewan, Choi, Jiwoong, Moon, Yujeong, Kim, Jinseong, Shim, Nayeon, Cho, Hanhee, Shim, Man Kyu, Jeon, Sangmin, Lim, Dong-Kwon, Yoon, Hong Yeol, Kim, Kwangmeyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954063/ https://www.ncbi.nlm.nih.gov/pubmed/35335852 http://dx.doi.org/10.3390/pharmaceutics14030474

Ejemplares similares

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
por: Choi, Yongwhan, et al.
Publicado: (2020)

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity
por: Shim, Man Kyu, et al.
Publicado: (2022)

Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
por: Cho, Hanhee, et al.
Publicado: (2021)

Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
por: Choi, Jiwoong, et al.
Publicado: (2022)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
por: Moon, Yujeong, et al.
Publicado: (2022)

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022)

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound
por: Choi, Yongwhan, et al.
Publicado: (2020)

Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy
por: Kim, Jeongrae, et al.
Publicado: (2022)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
por: Moon, Yujeong, et al.
Publicado: (2023)

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
por: Cho, Hanhee, et al.
Publicado: (2022)

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
por: Kim, Jeongrae, et al.
Publicado: (2023)

Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
por: Kim, Jinseong, et al.
Publicado: (2023)

In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
por: Chang, Hyeyoun, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy
por: Yun, Wan Su, et al.
Publicado: (2022)

Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
por: Yun, Wan Su, et al.
Publicado: (2023)

Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor Apoptosis
por: Shim, Man Kyu, et al.
Publicado: (2017)

Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-Therapy
por: Blaudszun, André-René, et al.
Publicado: (2023)

Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer
por: Cho, In Kyung, et al.
Publicado: (2022)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Iodinated Echogenic Glycol Chitosan Nanoparticles for X-ray CT/US Dual Imaging of Tumor
por: Choi, Daeil, et al.
Publicado: (2018)

The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts
por: Yhee, Ji Young, et al.
Publicado: (2017)

Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
por: Gao, Li, et al.
Publicado: (2019)

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
por: Lim, Seungho, et al.
Publicado: (2019)

Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound
por: You, Dong Gil, et al.
Publicado: (2017)

Assessment of Residual Solvent and Drug in PLGA Microspheres by Derivative Thermogravimetry
por: Shim, Hyunjin, et al.
Publicado: (2020)

Doxorubicin and CD-CUR inclusion complex co-loaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma
por: Yang, Zhiming, et al.
Publicado: (2020)

Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy
por: He, Peng, et al.
Publicado: (2022)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Prediction of IGS RTS Orbit Correction Using LSTM Network at the Time of IOD Change
por: Kim, Beomsoo, et al.
Publicado: (2022)

RESOLFT nanoscopy with photoswitchable organic fluorophores
por: Kwon, Jiwoong, et al.
Publicado: (2015)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
por: Rezaeian Shiadeh, Seyedeh Nesa, et al.
Publicado: (2023)

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)

Thiol-Responsive Gold Nanodot Swarm with Glycol Chitosan for Photothermal Cancer Therapy
por: Jo, SeongHoon, et al.
Publicado: (2021)

Physiological Effects of Ac4ManNAz and Optimization of Metabolic Labeling for Cell Tracking
por: Han, Sang-Soo, et al.
Publicado: (2017)

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
por: Yoon, Hong Yeol, et al.
Publicado: (2014)

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers
por: Wohlfart, Stefanie, et al.
Publicado: (2011)

Evaluation of Electrospun PCL-PLGA for Sustained Delivery of Kartogenin
por: Elder, Steven, et al.
Publicado: (2022)

Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis
por: Pentecost, Amanda, et al.
Publicado: (2019)

PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
por: Ma, Wenxue, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nugmp3a4dt6nisat12gq80tf9e